Vertex Pharmaceuticals Inc
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Vertex Pharmaceuticals Inc in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Vertex Pharmaceuticals Inc.
Recent articles on PMLiVE featuring Vertex Pharmaceuticals Inc
The agreement gives Vertex the rights to use Orum’s targeted protein degradation technology
The partners have been working together since 2018 to develop treatments for serious diseases
The company will gain rights to Alpine’s lead molecule, povetacicept, to treat IgA nephropathy
The company compared the treatment to its current triple cystic fibrosis therapy
Vertex/CRISPR and bluebird bio’s gene therapies have been approved to treat patients aged 12 years and older
Kaftrio and Kalydeco are now approved for use in certain patients aged two to five years
If approved, exa-cel will be the first genetic therapy available to treat patients with severe sickle cell disease
Amended agreement sees Vertex take control of gene therapy programme
Recent years have seen a significant shift in drug development to specialty areas
The latest movers in pharma
Pressure to reach a deal in England mounts
In other news, Vertex fires chief operating officer
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology